Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by SPCEO1


T.TH

RE:RE:RE:RE:RE:RE:Not surprising

I get info fromt he analyst reports and other people who are knowlegeable and...

December 2, 2022

T.TH

RE:RE:RE:RE:Not surprising

TH is saying it is all about efficacy not being adequate, less about safety...

December 2, 2022

T.TH

RE:RE:RE:RE:RE:Not surprising

I think one can safely say they made this change because they were not...

December 2, 2022

T.TH

RE:RE:RE:RE:Not surprising

You said "And now with lower and more frequent dosing, they will...

December 2, 2022

T.TH

RE:RE:Not surprising

I know everyone is distressed by the news on TH-1902 but the legacy drugs...

December 2, 2022

T.TH

RE:Fool me 4 times shame on you... this is the 5th...

I will need to hear more before drawing any conclusions but I think we all...

December 1, 2022

T.TH

RE:Silver lining

Tomorrow will be rough but there really never has been any value given to...

December 1, 2022

T.TH

RE:RE:RE:Woe are us.

Always glad to see you posting as it is highly correlated with the stock...

December 1, 2022

T.TH

RE:Woe are us.

The Cantor report was, at best, OK and got us a nice, semi-temporary pop...

December 1, 2022

T.TH

RE:RE:Jones Report is very good

Here is a snippet from the report I thought you might like seeing JFM...

November 30, 2022

T.TH

Jones Report is very good

I had a chance to look at it more closely and it is the best report ever done...

November 30, 2022

T.TH

RE:JonesTrading initiates Buy & sets $6 price target

I have had a quick look at the report and it seems well done. It  is 36...

November 30, 2022

T.TH

THTX to participate in Cantor NASH conference

Cantor Virtual KOL Call to Discuss Investigational Treatments for...

November 29, 2022

T.TH

RE:RE:RE:Let's hope

Yes, she seems to at least occasionally read this board. As she should since...

November 24, 2022

T.TH

RE:Let's hope

FYI - got a Happy Thanksgiving e-mail from the head of IR. She jokingly...

November 23, 2022

T.TH

RE:Is THTX trading today?

There is a bid and ask but no trades yet. Hard to believe that is the case so...

November 22, 2022

T.TH

RE:RE:RE:RE:RE:RE:RE:Cantor report effect

You still have some time left so don't throw in the towel yet! ...

November 22, 2022

T.TH

RE:RE:RE:RE:Cantor report effect

Soleus is an asset manager so they do not publish their research but use it...

November 21, 2022

T.TH

RE:RE:Cantor report effect

Chill Biobob. Cantor's report was a nice step in the right direction but...

November 21, 2022

T.TH

RE:RE:Merck AG initially bought US rights from Th

When they signed the partnership deal on Egrifta, they were targetting a...

November 21, 2022

Featured Company